The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age
- PMID: 32073649
- PMCID: PMC7288750
- DOI: 10.1002/cncr.32788
The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
Comment in
-
Reply to The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age.Cancer. 2020 Jun 1;126(11):2718-2719. doi: 10.1002/cncr.32791. Epub 2020 Feb 19. Cancer. 2020. PMID: 32073647 No abstract available.
Comment on
-
Age dependence of modern clinical risk groups for localized prostate cancer-A population-based study.Cancer. 2020 Apr 15;126(8):1691-1699. doi: 10.1002/cncr.32702. Epub 2020 Jan 3. Cancer. 2020. PMID: 31899813 Free PMC article.
References
-
- Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2006. National Cancer Institute; 2009.
-
- Cho H, Howlader N, Mariotto AB, Cronin KA. Estimating relative survival for cancer patients from the SEER program using expected rates based on Ederer I versus Ederer II method. Technical Report. Surveillance Research Program, National Cancer Institute; 2011.
-
- Arias E United States life tables, 2002. Natl Vital Stat Rep. 2004;53:1–38. - PubMed
-
- Pilat M Life expectancy in the U.S. population. Wolfram Demonstrations Project Published March 7, 2011. Accessed January 6, 2020 http://demonstrations.wolfram.com/LifeExpectancyInTheUSPopulation/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
